---
title: "Allarity Therapeutics (ALLR.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ALLR.US/norm.md"
symbol: "ALLR.US"
name: "Allarity Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/ALLR.US.md"
datetime: "2026-03-09T16:56:51.868Z"
locales:
  - [en](https://longbridge.com/en/quote/ALLR.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALLR.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALLR.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ALLR.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ALLR.US/norm.md)


# Allarity Therapeutics (ALLR.US) — 财务报表

## 利润表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1904 | -0.1493 | -0.2451 | -1.72 | -7.71 |
| ROE | -92.84% | -60.19% | -71.71% | -240.66% | -296.40% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -2.81M | -2.32M | -2.73M | -7.45M | -12.15M |
| 营业利润 | -2.52M | -4.13M | -3.04M | -7.32M | -2.61M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 20.80M | 21.20M | 29.73M | 22.65M | 20.38M |
| 权益乘数 | 1.73 | 1.74 | 1.59 | 1.92 | 1.57 |
| 每股净资产 | 0.7455 | 0.8322 | 1.10 | 1.62 | 4.70 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 16.89M | 17.80M | 25.20M | 19.61M | 18.46M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 330000.00 | 322000.00 | 308000.00 | 309000.00 | 12000.00 |
| 净债务 | -15.51M | -16.43M | -23.84M | -18.25M | -17.13M |

## 现金流量表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -3.41M | -5.48M | -2.69M | -3.21M | -5.44M |
| 投资现金流 | - | - | - | -298000.00 | - |
| 融资现金流 | 2.31M | -2.56M | 11.14M | 4.24M | 4.87M |
| 自由现金流 | -2.24M | -3.30M | -3.02M | -1.89M | -4.65M |
| 现金流充裕率 | - | - | - | -1075.84% | - |
| 举债与偿债 | - | - | - | 0.0000 | 0.0000 |
| 资本支出 | - | - | - | -298000.00 | - |